Under such a partnership construction, where Merrimack would leave the marketing and distribution to a major pharmaceutical, what would be the part of the royaltee pie remaining for GTCB (next to a margin on the manufacturing of the purified raw material)? What would be a reasonable percentage?
Market Data 
Markets 
AI
